Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.72 HKD | -1.47% | +3.32% | -56.09% |
01:09am | Genscript Biotech's Phase 3 Multiple Myeloma Drug Trial Yields Positive Results | MT |
Jun. 28 | Genscript Biotech Units Receive Milestone Payment of $30 Million | MT |
- Stock Market
- Equities
- 1548 Stock
- News Genscript Biotech Corporation
- MarketScreener Editorial Features